{"slug":"global","tag":"global","variants":["global"],"description":"No description yet","count":5,"kinds":{"cancer":1,"technology":3,"term":1},"related":[{"slug":"access","tag":"access","shared":2},{"slug":"measurement","tag":"measurement","shared":2},{"slug":"rejuvenation","tag":"rejuvenation","shared":2},{"slug":"survivorship","tag":"survivorship","shared":2},{"slug":"cost","tag":"cost","shared":1},{"slug":"equity","tag":"equity","shared":1},{"slug":"policy","tag":"policy","shared":1},{"slug":"skin","tag":"skin","shared":1},{"slug":"viral","tag":"viral","shared":1}],"records":[{"id":"kaposi-sarcoma","kind":"cancer","name":"Kaposi sarcoma","route":"/cancers/kaposi-sarcoma/","tldr":"Kaposi sarcoma is a blood-vessel cancer caused by the herpesvirus HHV-8, made famous by the AIDS epidemic. In people with HIV, antiretroviral therapy alone often shrinks it; liposomal doxorubicin or paclitaxel treat advanced disease, and it remains among the commonest cancers in sub-Saharan Africa, where paclitaxel is often unaffordable."},{"id":"global-oncology-access","kind":"technology","name":"Global oncology and access in low- and middle-income countries","route":"/technologies/global-oncology-access/","status":"emerging","tldr":"Seventy percent of cancer deaths occur in low- and middle-income countries, where radiotherapy machines, pathologists, essential medicines and palliative care are scarce. Global oncology works on affordable, adapted care and the systems to deliver it."},{"id":"who-essential-medicines","kind":"term","name":"WHO Essential Medicines List for cancer","route":"/terms/who-essential-medicines/","tldr":"The World Health Organization's list of medicines every health system should provide, which now includes about 60 cancer drugs from cyclophosphamide and cisplatin to trastuzumab, imatinib and PD-1 inhibitors, guiding procurement and pricing in lower-income countries."},{"id":"rejuv-access-survivorship-care-lmic","kind":"technology","name":"After treatment in low and middle income countries: mostly nothing","route":"/technologies/rejuv-access-survivorship-care-lmic/","status":"emerging","tldr":"Most people in the world who survive cancer are offered no survivorship care at all. Specialist centres are rare, follow-up is limited, late effects are poorly documented, and the household pays. This is the largest gap in recovery care anywhere, and the one with the thinnest evidence base."},{"id":"rejuv-access-what-it-costs-elsewhere","kind":"technology","name":"What recovery costs in the rest of the world","route":"/technologies/rejuv-access-what-it-costs-elsewhere/","status":"emerging","tldr":"In Germany rehabilitation is an entitlement with the outpatient version free to the patient. In most of the world there is no survivorship service to be charged for, and the household pays for whatever follow-up happens. Reliable comparative figures do not exist."}]}